期刊文献+

骨髓单个核细胞治疗缺血性心力衰竭初步研究报告 被引量:5

暂未订购
导出
摘要 心肌梗死后出现心力衰竭是临床常见并发症。近几年来,ACEI、ARB和β受体阻滞剂的应用使心力衰竭的预后有明显改善,但病死率仍很高,约20%。心肌细胞没有再生能力,心肌梗死一旦发生,心肌内可收缩细胞将永久性地减少。
出处 《中国心血管病研究》 CAS 2004年第4期285-286,共2页 Chinese Journal of Cardiovascular Research
  • 相关文献

参考文献10

  • 1[1]Eichhorn E J, Bristow MR. The Carvedilol Prospective Randomized Cumulative Survival(COPERNICUS) trial[J]. Curr Control Trials Cardiovasc Med, 2001,2( 1 ):20 - 23
  • 2[2]Mac Carthy PA, Kearney MT, Nolan J, et al. Prognosis in heart failure with preserved left ventricular systolic function: prospective cohort study [ J ]. BM J, 2003,327(7406): 78 - 79
  • 3[3]Hughes S. Cardiac stem cells[J ]. J Pathol, 2002, 197(4) :468 - 478
  • 4[4]Orlic D. Adult Bone Marrow Stem Cells Regenerate Myocardium in Ischemic Heart Disease[J]. Annals of the New York Academy of Sciences, 2003,996:152 -157
  • 5[5]Orlic D, Kajstura J, Chimenti S, et al. Transplanted adult bone marrow cells repair myocardial infarcts in mice[J]. Ann N Y Acad Sci,2001,938:221 -229
  • 6[6]Kinnaird TD, Stabile E, Bumett MS, et al. Mesenchymal stromal cell transplantation contributes to collateral response in tissue ischemia through release of arterogenic cytokines[ J ]. J Am Coll Cardiol, 2003,41 (Suppl A) :67A. Abstract 1176 - 1179
  • 7[7]Schachinger V, Assmus B, Lehmann R, et al. Clinical evidence for benefit of intracoronary progenitor cell therapy on post - infarction remodeling: results of the TOPCARE-AMI trial [J ]. J Am Coll Cardiol, 2003,41 (Suppl A):4.04A. Abstract 881 - 882
  • 8[8]St. John ME, Xie J, Heldman AW, et al. Catheterbased percutaneous cellular cardiomyoplasty using allogeneic bone marrow derived mesenchymal stem cells[J].J Am Coll Cardiol,2003,41 (Suppl A):67A. Abstract 1176- 1177
  • 9[9]Perin EC, Dohmann HF, Borojevic R, et al. Improvement in symptoms and exercise capacity at eight weeks in a controlled study of autologous bone marrow cell transplant in humans with severe ischemic heart failure[J]. J Am Coll Cardiol, 2003,41 (Suppl A): 44A. Abstract 823 - 824
  • 10[10]Wang JS, Shum - Tim D, Galipean J, et al. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages[ J ]. J thorac Cardiovasc Surg,2000,120(5) :999 - 1005

同被引文献25

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部